Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.54, Iss.6, 2013-06, pp. : 1279-1287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Up-regulation of P-glycoprotein confers acquired resistance to 6-mercaptopurine in human chronic myeloid leukemia cells

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 549-556

Spandidos Publications

Access to resources Recommend Favorite

慢性髓细胞白血病对伊马替尼产生耐药性的机制 Imatinib Resistance Mechanism on Chronic Myeloid Leukemia

By 夏君燕朱平

World Journal of Cancer Research, Vol. 02, Iss. 03, 2012-07 ,pp. : 15-19

汉斯出版社

Access to resources Recommend Favorite

A novel compound against oncogenic Aurora kinase A overcomes imatinib resistance in chronic myeloid leukemia cells

International Journal of Oncology, Vol. 46, Iss. 6, 2015-01 ,pp. : 2488-2496

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells

By Kim Sung Su Seong Sin Kim Sung Young

Oncology Letters, Vol. 7, Iss. 4, 2014-04 ,pp. : 1265-1269

Spandidos Publications

Access to resources Recommend Favorite

Role and mechanisms of microRNA503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3268-3274

Spandidos Publications

Access to resources Recommend Favorite